Skip to main content
TipRanks
Go Ultimate75% OFF

Healixa Inc (EMOR) Ratios

8 Followers

Healixa Inc Ratios

EMOR's free cash flow for Q1 2026 was $-119.45K. For the 2026 fiscal year, EMOR's free cash flow was decreased by $-4.00 and operating cash flow was $-119.45K. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio0.030.020.040.030.03
Quick Ratio0.030.020.040.030.03
Cash Ratio0.020.000.010.000.02
Solvency Ratio-0.06-0.08-0.63-0.05-0.45
Operating Cash Flow Ratio0.00-0.03-0.08-0.19-0.27
Short-Term Operating Cash Flow Coverage0.00-0.04-0.13-0.38-0.53
Net Current Asset Value$ -9.58M$ -9.01M$ -10.11M$ -11.08M$ -6.11M
Leverage Ratios
Debt-to-Assets Ratio20.8828.6210.559.968.40
Debt-to-Equity Ratio-0.70-0.73-0.66-0.51-0.55
Debt-to-Capital Ratio-2.30-2.65-1.97-1.06-1.20
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio-0.03-0.03-0.06-0.05-0.07
Debt Service Coverage Ratio-0.15-0.07-0.91-0.09-0.76
Interest Coverage Ratio-3.17-1.69-16.71-1.01-11.71
Debt to Market Cap0.220.210.060.040.00
Interest Debt Per Share0.010.010.010.010.00
Net Debt to EBITDA-6.34-14.02-1.03-10.69-1.19
Profitability Margins
Gross Profit Margin0.00%56.07%35.20%-275.29%0.00%
EBIT Margin1083.29%-67.60%-1060.88%-6292.10%0.00%
EBITDA Margin1083.29%-66.02%-1055.35%-5916.81%0.00%
Operating Profit Margin1083.29%-67.60%-1060.88%-6292.11%0.00%
Pretax Profit Margin599.38%-107.68%-1123.79%-7316.07%0.00%
Net Profit Margin599.38%-107.68%-1123.79%-7316.07%0.00%
Continuous Operations Profit Margin599.38%-107.68%-1123.79%-7316.07%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT55.33%159.30%105.93%116.27%108.54%
Return on Assets (ROA)-177.04%-331.04%-1076.89%-114.71%-738.90%
Return on Equity (ROE)5.91%8.40%67.65%5.93%48.04%
Return on Capital Employed (ROCE)10.68%5.27%63.86%5.10%44.45%
Return on Invested Capital (ROIC)35.25%19.25%189.50%10.51%97.55%
Return on Tangible Assets-177.04%-331.04%-1319.73%-194.01%-1837.04%
Earnings Yield-1.85%-2.47%-6.22%-0.46%-0.40%
Efficiency Ratios
Receivables Turnover-3.373.812.461.430.00
Payables Turnover0.000.590.630.030.05
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.0054.260.200.00
Asset Turnover-0.303.070.960.020.00
Working Capital Turnover Ratio0.01-0.07-0.06-0.000.00
Cash Conversion Cycle-108.21-517.90-429.84-13608.19-6797.86
Days of Sales Outstanding-108.2195.81148.14255.770.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.00613.71577.9813863.966797.86
Operating Cycle-108.2195.81148.14255.770.00
Cash Flow Ratios
Operating Cash Flow Per Share0.00-0.00-0.00-0.00-0.00
Free Cash Flow Per Share0.00-0.00-0.00-0.00-0.00
Dividend Paid and CapEx Coverage Ratio7801.00-66351.50-219841.500.00-14.73
Capital Expenditure Coverage Ratio7801.00-66351.50-219841.500.00-14.73
Operating Cash Flow Coverage Ratio0.00-0.04-0.13-0.38-0.52
Operating Cash Flow to Sales Ratio-0.25-0.38-1.47-242.500.00
Free Cash Flow Yield0.08%-0.87%-0.81%-1.53%-0.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-54.18-40.00-16.08-216.99-252.93
Price-to-Sales (P/S) Ratio-324.7443.63180.6515875.430.00
Price-to-Book (P/B) Ratio-3.20-3.40-10.87-12.86-121.52
Price-to-Free Cash Flow (P/FCF) Ratio1310.64-115.55-123.03-65.47-397.50
Price-to-Operating Cash Flow Ratio1310.47-115.55-123.03-65.47-424.48
Price-to-Earnings Growth (PEG) Ratio0.540.45-0.022.813.12
Enterprise Value Multiple-36.31-80.10-18.15-279.00-278.16
Enterprise Value37.15M37.17M114.70M145.63M722.16M
EV to EBITDA-36.31-80.10-18.15-279.00-278.16
EV to Sales-393.3752.88191.5116507.940.00
EV to Free Cash Flow1587.62-140.06-130.43-68.07-399.21
EV to Operating Cash Flow1587.41-140.06-130.43-68.07-426.31
Tangible Book Value Per Share-0.01-0.01-0.01-0.01-0.01
Shareholders’ Equity Per Share-0.01-0.01-0.01-0.01-0.01
Tax and Other Ratios
Effective Tax Rate0.000.00-0.000.000.00
Revenue Per Share-0.000.000.000.000.00
Net Income Per Share-0.00-0.00-0.01-0.00-0.00
Tax Burden1.001.001.001.001.00
Interest Burden0.551.591.061.161.09
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue-9.831.240.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality-0.040.350.133.310.60

Currency in USD